DK1638582T3 - Anvendelse af hyaluronsyre til fremstilling af kompositioner til behandling af tilbagevendende after - Google Patents

Anvendelse af hyaluronsyre til fremstilling af kompositioner til behandling af tilbagevendende after

Info

Publication number
DK1638582T3
DK1638582T3 DK04766068T DK04766068T DK1638582T3 DK 1638582 T3 DK1638582 T3 DK 1638582T3 DK 04766068 T DK04766068 T DK 04766068T DK 04766068 T DK04766068 T DK 04766068T DK 1638582 T3 DK1638582 T3 DK 1638582T3
Authority
DK
Denmark
Prior art keywords
hyaluronic acid
compositions
preparation
treatment
recurrent seizures
Prior art date
Application number
DK04766068T
Other languages
Danish (da)
English (en)
Inventor
Franco Macchi
Original Assignee
Bioplax Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=30131290&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1638582(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bioplax Ltd filed Critical Bioplax Ltd
Application granted granted Critical
Publication of DK1638582T3 publication Critical patent/DK1638582T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK04766068T 2003-06-25 2004-06-23 Anvendelse af hyaluronsyre til fremstilling af kompositioner til behandling af tilbagevendende after DK1638582T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001291A ITMI20031291A1 (it) 2003-06-25 2003-06-25 Uso di acido ialuronico per la preparazione di composizioni per il trattamento di afte del cavo orale.
PCT/EP2004/051209 WO2005000321A1 (en) 2003-06-25 2004-06-23 Use of hyaluronic acid for preparing compositions for treating oral cavity aphthas

Publications (1)

Publication Number Publication Date
DK1638582T3 true DK1638582T3 (da) 2009-05-18

Family

ID=30131290

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04766068T DK1638582T3 (da) 2003-06-25 2004-06-23 Anvendelse af hyaluronsyre til fremstilling af kompositioner til behandling af tilbagevendende after

Country Status (17)

Country Link
US (1) US10245280B2 (pt)
EP (1) EP1638582B1 (pt)
JP (1) JP4728955B2 (pt)
CN (1) CN1812798B (pt)
AT (1) ATE422892T1 (pt)
BR (1) BRPI0411702B8 (pt)
CA (1) CA2529441C (pt)
CY (1) CY1108992T1 (pt)
DE (1) DE602004019528D1 (pt)
DK (1) DK1638582T3 (pt)
ES (1) ES2322060T3 (pt)
IT (1) ITMI20031291A1 (pt)
MX (1) MXPA05014184A (pt)
PL (1) PL1638582T3 (pt)
PT (1) PT1638582E (pt)
SI (1) SI1638582T1 (pt)
WO (1) WO2005000321A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005530768A (ja) * 2002-05-09 2005-10-13 メディジーンズ 血漿または血清を含有した創傷治療用医薬組成物
US7323184B2 (en) * 2005-08-22 2008-01-29 Healagenics, Inc. Compositions and methods for the treatment of wounds and the reduction of scar formation
ITMI20081450A1 (it) * 2008-08-04 2010-02-05 Biofarmitalia Spa Pellicola solida a rapida dissoluzione nei liquidi
IT1396468B1 (it) * 2008-11-11 2012-12-14 Farma Derma Srl Uso topico di acido ialuronico ad azione filmogena in preparati per il trattamento e profilassi di patologie delle vie respiratorie.
ES2388281B1 (es) 2010-12-27 2013-10-01 Laboratorios Viñas S.A. Composición farmacéutica que comprende ácido hialurónico y un compuesto de zinc y pastilla con palito y procedimiento para preparación correspondientes
JP5840107B2 (ja) * 2012-06-17 2016-01-06 コスメディ製薬株式会社 ヒアルロン酸ゲル及びその製造方法
CN103860526A (zh) * 2013-11-26 2014-06-18 华熙福瑞达生物医药有限公司 一种含透明质酸的消毒剂、其制备方法及用途
EP3056195A1 (en) 2015-02-13 2016-08-17 Vision:Organic GmbH Compositions comprising hyaluronic acid and beta-glucan for topical applications in oral cavity
ITUB20153699A1 (it) * 2015-09-17 2017-03-17 Fastmeditalia Srl Integratore orale
IT201700048750A1 (it) * 2017-05-05 2018-11-05 Farm Procemsa S P A Composizione per il trattamento di afte e ulcere buccali
GB201713362D0 (en) * 2017-08-21 2017-10-04 Givaudan Sa Improvements in or relating to organic compounds
CN108210689A (zh) * 2017-11-27 2018-06-29 南京天纵易康生物科技股份有限公司 一种含有透明质酸的口腔溃疡膜剂及其制备方法
EP4230212A1 (en) 2022-02-16 2023-08-23 UNIVERSITÄTSmedizin der Johannes Gutenberg- Universität Mainz Composition and kits for the prevention or treatment of gum diseases
IT202200010439A1 (it) * 2022-05-19 2023-11-19 Anatek Health Italia S R L Composizione comprendente acido nevronico e beta-cariofillene nel trattamento della mucosite

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US183278A (en) * 1876-10-17 Improvement in ventilating-cowls
IT1240316B (it) 1990-02-21 1993-12-07 Ricerca Di Schiena Del Dr. Michele G. Di Schiema & C. Composizioni a base di acido ialuronico ad alto peso molecolare somministrabili per via topica per il trattamento di infiammazioni del cavo orale ,per la cosmetica e l'igiene del cavo orale
US5972906A (en) * 1991-07-03 1999-10-26 Hyal Pharmaceutical Corporation Treatment of mucous membrane disease, trauma or condition and for the relief of pain thereof
US6828308B2 (en) * 2000-07-28 2004-12-07 Sinclair Pharmaceuticals, Ltd. Compositions and methods for the treatment or prevention of inflammation
IT1318649B1 (it) 2000-07-28 2003-08-27 Propharma S R L Ora Sinclair P Composizioni farmaceutiche per il trattamento di mucositi e stomatiti.

Also Published As

Publication number Publication date
CA2529441A1 (en) 2005-01-06
BRPI0411702B1 (pt) 2019-08-13
ATE422892T1 (de) 2009-03-15
ES2322060T3 (es) 2009-06-16
US20060147393A1 (en) 2006-07-06
JP4728955B2 (ja) 2011-07-20
PT1638582E (pt) 2009-05-28
EP1638582B1 (en) 2009-02-18
MXPA05014184A (es) 2006-03-09
JP2009513492A (ja) 2009-04-02
CN1812798B (zh) 2011-02-09
BRPI0411702B8 (pt) 2021-05-25
SI1638582T1 (sl) 2009-10-31
CN1812798A (zh) 2006-08-02
ITMI20031291A1 (it) 2004-12-26
PL1638582T3 (pl) 2009-07-31
EP1638582A1 (en) 2006-03-29
BRPI0411702A (pt) 2006-08-08
DE602004019528D1 (de) 2009-04-02
ITMI20031291A0 (it) 2003-06-25
CA2529441C (en) 2012-12-04
US10245280B2 (en) 2019-04-02
CY1108992T1 (el) 2014-07-02
WO2005000321A1 (en) 2005-01-06

Similar Documents

Publication Publication Date Title
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
MY143795A (en) Tetrahydropyridoindole derivatives
CY1108992T1 (el) Η χρηση του υαλουρονικου οξεος για την παρασκευη συνθεσεων για τη θεραπευτικη αντιμετωπιση υποτροπιαζουσων αφθων της στοματικης κοιλοτητας
TW200606162A (en) Pyrazolopyridine derivatives
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
HK1085140A1 (en) Pharmaceutical compositions and method of using levodopa and carbidopa
PL372809A1 (en) Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof
EA200501268A1 (ru) Ингибирующие вич 1,2,4-триазины
ATE486587T1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
ATE350377T1 (de) Substituierte 3-pyrrolidin-indol-derivate
DK1641803T3 (da) Thienopyrimidinderivater som kaliumkanalinhibitorer
BRPI0411673A (pt) composto, sal farmaceuticamente aceitável, composição farmacêutica, e, uso de um composto
CY1109366T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης
NO20071798L (no) Dermalt pafore formuleringer for behandling av hudsykdommer i dyr
TW200626581A (en) Compounds, compositions containing them, preparation thereof and uses thereof
UA83821C2 (ru) Производные бензолсульфонамидов, способ их получения и их применение для лечения воспалительных заболеваний и утоления боли
UY26895A1 (es) Compuestos de pirazol, composiciones farmacéuticas, y métodos para modular y/o inhibir la actividad de erab/hadh2
DK1537132T3 (da) Salt af mortin-6-glucuronid
MXPA04005265A (es) Uso de derivados del acido 4-oxobutanoico para el tratamiento contra inflamacion.
EA200701086A1 (ru) Производные изоксазола, их фармацевтические композиции и способ лечения невропатической боли
ZA200605653B (en) Proline derivatives used as pharmaceutical active ingredients for the treatment of tumours
TW200614991A (en) Novel compounds
TW200626583A (en) Novel compounds
TW200621750A (en) Compounds, compositions containing them, preparation thereof and uses thereof
TW200616970A (en) Compounds, compositions containing them, preparation thereof and uses thereof